EN PL
ORIGINAL PAPER
Granulomatosis with polyangiitis in Poland – epidemiological study
 
More details
Hide details
 
Submission date: 2014-03-04
 
 
Acceptance date: 2014-05-19
 
 
Online publication date: 2014-06-04
 
 
Publication date: 2014-04-30
 
 
Reumatologia 2014;52(2):99-104
 
KEYWORDS
TOPICS
ABSTRACT
Aim of the study: Granulomatosis with polyangiitis (GPA) is a disease of unknown aetiology, with a variable course, and with the possibility of exacerbations associated with life-threatening organ damage. Data on the incidence of GPA in Poland are limited. Epidemiological analysis can provide a lot of information that contributes to more accurate knowledge about GPA. The objective of this study was to conduct an analysis of GPA incidence in Poland with comparison of results to selected European countries. An additional analysis was performed according to the distribution of gender, age and hospitalization structure in GPA patients.
Material and methods: The estimation of GPA incidence was based on data taken from the Polish hospital morbidity registry of the National Institute of Public Health, in the scope of which data on all inpatients discharged from non-psychiatric hospitals in Poland are collected. Analysed data covered 1112 medical records taken from the first time of hospitalization records with diagnosis of GPA. The observation time ranged from December 2004 to December 2010.
Results: The average annual incidence of GPA in Poland was estimated to be 4.9/million in the general population, 5.8/million in the adult population and 1/million in the population of patients below 18 years of age. The annual incidence in Poland was comparable to incidence data from other European countries. The analysis of hospitalizations showed that the GPA patients were most often hospitalized in pulmonary, nephrology and rheumatology departments. During the observation period hospitalizations ended with death in 80 patients and GPA as an underlying cause of death was reported in 60 cases.
Conclusions: In this study GPA incidence in Poland was estimated. Analyses of the structure of hospitalizations suggested that symptoms from the respiratory tract, kidneys and joints could be leading symptoms in the early stage of GPA development.
 
REFERENCES (32)
1.
Abdou N, Kullman G, Hoffman GS, et al. Wegener’s granulomatosis: a survey of 701 patients in North America.Changesin outcome in the 1990s. J Rheumatol 2002; 29: 309-316. .
 
2.
Rottem M, Fauci AS, Hallahan CW, et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993; 122: 26-31. .
 
3.
Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, et al. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003; 49: 388-393. .
 
4.
Cotch MF, Hoffman GS, Yerg DE, et al. The epidemiology of Wegener’s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996; 39: 87-92. .
 
5.
Watts RA, Lane SE, Scott DG, et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001; 60):1156-1157. .
 
6.
Koldingsnes W, Nossent H. Epidemiology of Wegener’s granulomatosis in northern Norway. Arthritis Rheum 2000; 43: 2481-2487. .
 
7.
Watts RA, Lane SE, Bentham G, et al. Epidemiology of systemic vasculitis: a ten year study in the United Kingdom. Arthritis Rheum 2000; 43: 414-419. .
 
8.
Mohammad AJ, Jacobsson LT, Mahr AD, et al. Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology 2007; 46: 1329-1337. .
 
9.
Gibson A, Stamp LK, Chapman PT, O’Donnell JL. The epidemiology of Wegener’s granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford) 2006; 45: 624-628. .
 
10.
Carruthers DM, Watts RA, Symmons DP, Scott DG. Wegener’s granulomatosis – increased incidence or increased recognition? Br J Rheumatol 1996; 35: 142-145. .
 
11.
Haugeberg G, Bie R, Bendvold A, et al. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol.1998; 17: 364-368. .
 
12.
Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999; 78: 292-308. .
 
13.
Reinhold-Keller E, Zeidler A, Gutfleisch J, et al. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 2000; 39: 1396-1402. .
 
14.
Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, et al. No difference in the incidences of vasculitides between northand south Germany: first results of the German Vasculitis Register. Rheumatology (Oxford) 2002; 41: 540-549. .
 
15.
Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, et al. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum.2005; 53: 93-9. .
 
16.
Mohammad A, Jacobsson L, Segelmark M, et al. Prevalence of small vessel vasculitis in Sweden – preliminary report (abstract). Kidney Blood Press Res 2003; 26: 251. .
 
17.
Knight A, Ekbom A, Brandt L, Askling J. Increasing incidence of Wegener’s granulomatosis in Sweden 1975–2001 (abstract). Arthritis Rheum 2005; 52: S403. .
 
18.
Wislowska M, Gozdowska J. Wegener’s granulomatosis – observation of cases. Reumatologia 2008; 46: 68-71. .
 
19.
Matuszewska A, Misterska-Skóra M, Wiland P. A case of early recognized Wegener’s granulomatosis with renal involvement. Insight for early diagnosis. Ann Acad Med Stetitensis 2010; 56: 41-44. .
 
20.
 
22.
Watts RA, Al-Taiar A, Scott DG, et al. Prevalence and incidence of Wegener’s granulomatosis in the UK general practice research database. Arthritis Rheum 2009; 61: 1412-1416. .
 
23.
Herlyn K, Hellmich B, Gross WL, et al. Stable Incidence of Systemic Vasculitides in Schleswig-Holstein, Germany. Dtsch Arztebl Int 2008; 105: 355-361. .
 
24.
Knight A, Ekbom A, Brandt L, Askling J. Increasing incidence of Wegener’s granulomatosis in Sweden 1975–2001. J Rheumatol 2006; 33: 2060-2063. .
 
25.
Takala J. Wegener’s granulomatosis in Finland in 1981-2000. Akademic Dissertation, Helsinki 2011. https://helda.helsinki.fi/ bitstream/handle/10138/27729/wegeners.pdf?sequence=1, [11-08-2012]. .
 
26.
Gisaru S, Yuen GW, Miettunen PM, et al. Incidence of Wegener’s granulomatosis in children. J Rheumatol 2010; 37: 440-442. .
 
27.
Duna GF, Cotch MF, Galperin C. Wegener’s granulomatosis: role of environmental exposures. Clin Exp Rheumatol 1998; 16: 669-674. .
 
28.
Tidman M, Olander R, Svalander C, et al. Patients hospitalized becauseof small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244: 133-141. .
 
29.
Raynauld JP, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener’s granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol 1993; 20: 1524-1526. .
 
30.
Tidman M, Olander R, Svalander C, Danielsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244: 133-141. .
 
31.
Reinhold-Keller E, Beuge N, Latza U, al. An interdisciplinary approach to the care of patients with Wegenerʼs granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021-1032. .
 
32.
Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-498.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top